Cost Effectiveness of Oral Terbinafine (Lamisil®) Compared with Oral Fluconazole (Diflucan®) in the Treatment of Patients with Toenail Onychomycosis

被引：0
|
作者：
Heini Salo
Markku Pekurinen
机构：
[1] Health Services Research Ltd,
[2] STAKES,undefined
来源：
PharmacoEconomics | 2002年 / 20卷
关键词：
Cost Effectiveness; Fluconazole; Terbinafine; Clinical Cure; Mycological Cure;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Objective: To determine the cost effectiveness of terbinafine (Lamisil®)1 tablets compared with fluconazole (Diflucan® ) capsules in the treatment of patients with toenail onychomycosis.
引用
收藏
页码：319 / 324
页数：5
相关论文
共 50 条
  • [21] Cost-Effectiveness of Oral Anticoagulants for Treatment of Atrial Fibrillation
    Canestaro, William J.
    Patrick, Amanda R.
    Avorn, Jerry
    Ito, Kouta
    Matlin, Olga S.
    Brennan, Troyen A.
    Shrank, William H.
    Choudhry, Niteesh K.
    CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES, 2013, 6 (06): : 724 - +
  • [22] Fluconazole versus oral polyenes in the prophylaxis of immunocompromised patients: A cost-minimization analysis
    Wakerly, L
    Craig, AM
    Malek, M
    Hoffmeyer, U
    Lloyd, A
    Valette, F
    Phillips, R
    Zabihollah, M
    JOURNAL OF HOSPITAL INFECTION, 1996, 33 (01) : 35 - 48
  • [23] Prognostic factors for the clinical effectiveness of fluconazole in the treatment of oral candidiasis in HIV-1-infected individuals
    Koks, CHW
    Crommentuyn, KML
    Mathôt, RAA
    Mulder, JW
    Meenhorst, PL
    Beijnen, JH
    PHARMACOLOGICAL RESEARCH, 2002, 46 (01) : 89 - 94
  • [24] Cost-effectiveness analysis of using oral magnesium supplementation in the treatment of prediabetes
    Guerrero-Romero, Fernando
    Nevarez-Sida, Armando
    PRIMARY CARE DIABETES, 2022, 16 (03) : 435 - 439
  • [25] Combined treatment with surgery and short duration oral antifungal therapy in patients with limited dermatophyte toenail infection
    Goodfield, MJD
    Evans, EGV
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2000, 11 (04) : 259 - 262
  • [26] Cost-effectiveness analysis of apixaban compared to other direct oral anticoagulants for prevention of stroke in Austrian atrial fibrillation patients
    Walter, Evelyn
    Voit, Marco
    Eichhober, Gerald
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2021, 21 (02) : 265 - 275
  • [27] Cost-Effectiveness of New Oral Anticoagulants Compared with Warfarin in Preventing Stroke and Other Cardiovascular Events in Patients with Atrial Fibrillation
    Coyle, Doug
    Coyle, Kathryn
    Cameron, Chris
    Lee, Karen
    Kelly, Shannon
    Steiner, Sabine
    Wells, George A.
    VALUE IN HEALTH, 2013, 16 (04) : 498 - 506
  • [28] Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine
    Prenzler, Anne
    Yen, Linnette
    Mittendorf, Thomas
    von der Schulenburg, J-Matthias
    BMC HEALTH SERVICES RESEARCH, 2011, 11
  • [29] Cost-effectiveness of new oral anticoagulants in the treatment and secondary prevention of venous thromboembolism
    Rudakova, A. V.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2015, 11 (05) : 496 - 503
  • [30] Cost effectiveness of ulcerative colitis treatment in Germany: a comparison of two oral formulations of mesalazine
    Anne Prenzler
    Linnette Yen
    Thomas Mittendorf
    J-Matthias von der Schulenburg
    BMC Health Services Research, 11
12345